New modalities hog the limelight
Explore how Cell and Gene, mRNA, Bispecifics, and ADCs are turning the tide as CDMOs see service demand for these therapies soar.
Bioanalytical outsourcing soars as drugs grow more complex
Outsourcing of bioanalytical lab services is set for explosive growth as the increasingly complex nature of modern-day therapeutics makes partnerships with CROs indispensable.
Net-zero pledge: CDMOs go greener
A number of CDMOs are accelerating their environmental drive as sustainability goals become one of the most urgent business strategies facing pharma companies today.
Powering up antibody-drug conjugates with PROTACS
Read this White Paper on the ADC alternative that is capturing scientists’ imagination – antibody-linked PROTACs and the impact it could have in oncology, neurology, virology, and agriculture.
Innovation at Syngene: Translatable models for improving cancer research
Syngene has developed orthotopic models validated against the standard of care and tumor models with 3D culture, which can help improve translatability and clinical relevance in cancer research.
pDNA and mRNA manufacturing in the age of Precision Therapies: The role of CDMOs
Challenges in pDNA manufacturing and why CDMOs are best suited for supplying pDNA for Precision Therapies.
How Sygnene delivered more than 90% purity pDNA for a global biotech using a proprietary platform process
Learn how Syngene used its proprietary platform process for pDNA manufacturing from discovery to the clinic to deliver >90% purity pDNA.
Catalogue of Regulatory In Vitro and Genetic Toxicology Screening Assays
Syngene International Corporate video
Catch a glimpse of our ~ 2 Mn sq. ft. world-class R&D and manufacturing facility to understand how we put ‘Science to Work’ at Syngene. We are an innovation-led, contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.
Syngene API manufacturing facility, Mangalore
Our GMP-certified, API manufacturing facility in Mangalore is a state-of-the-art, multi-product, multi-client, contract facility. Spread across 46 acres, it is designed to support all large-scale API and advanced intermediate manufacturing requirements of our clients.
